Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2008
11/05/2008EP1986621A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals
11/05/2008EP1986566A1 Accelerating agent of calcium absorption
11/05/2008EP1526140B1 Potassium-dependent sodium-calcium exchanger
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1162990B1 Treatment with small peptides to effect antifibrotic activity
11/05/2008CN101300030A Combination of an angiotensin II receptor blocker, a calcium channel blocker and another active agent
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101300003A Prevention of hypotension and stabilization of blood pressure in hemodialysis patients
11/05/2008CN101298479A Antibodies for inhibiting blood coagulation and methods of use thereof
11/05/2008CN101297990A Regimen using padauk and health-preserving pillow
11/05/2008CN101297974A Pegylated glycosides of aerial parts of epimedium, and preparation and use thereof
11/05/2008CN101297969A Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications
11/05/2008CN101297954A Unbilical medicament for treating cough and preparation thereof
11/05/2008CN101297950A Chinese medicine for preventing and treating atherosclerosis, coronary disease and preparation thereof
11/05/2008CN101297897A Chinese medicine preparation for treating cardiovascular and cerebrovascular disease
11/05/2008CN101297884A Prescription of low-dose condensed type Mai jun an tablet or capsule and preparation thereof
11/05/2008CN101297881A Chinese medicine prescription for treating piles
11/05/2008CN101297864A Preparation of Xia sang ju formulation
11/05/2008CN101297855A Chinese medicine preparation for treating paralysis agitans
11/05/2008CN101297828A Uses of Petasites tricholobus franch extract in medicament preparation for preventing and controlling cardiovascular and cerebrovascular diseases
11/05/2008CN101297827A Medicament for curing coronary disease and coronary artery coating bracket coated therewith
11/05/2008CN101297825A Compound formulation of ginkgo leaf extract
11/05/2008CN101297811A Compound antiarrhythmic
11/05/2008CN101297807A The use of 5-HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
11/05/2008CN101297801A Medicament use of 5-hydroxymethyl furfural
11/05/2008CN101297791A Alprostadil composition and preparation thereof
11/05/2008CN101297706A Garlic essence oral liquid and preparation thereof
11/05/2008CN101297672A Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal
11/05/2008CN100430409C Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430383C Benzimidazoles that are useful in treating sexual dysfunction
11/05/2008CN100430090C A composition for the prevention and/or treatment of atherosclerosis
11/05/2008CN100430081C Chinese medicine for treating hypotension
11/05/2008CN100430079C Chinese medicine for treating heart disease
11/05/2008CN100430074C Chinese medicine for treating haemorrhoids
11/05/2008CN100430072C Chinese-medicinal preparation for treating cardiovascular and cerebrovascular diseases
11/05/2008CN100430070C Medication for treating coronary heart disease and angina
11/05/2008CN100430068C Chinese medicine for treating cardiomyopathy
11/05/2008CN100430057C Pharmaceutical compositions of levoamlodipine and atorvastatin
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/04/2008US7446201 Substituted heteroaryl benzofuran acids
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445775 Mammalian nucleotide sequence coding plasminogen catalytic domain and optionally kringle domains linked to promoter; ischemic stroke, arterial thrombotic diseases
11/04/2008CA2325360C Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
10/2008
10/30/2008WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
10/30/2008WO2008130951A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
10/30/2008WO2008129980A1 Particulate composition comprising reduced coenzyme q10, and method for production thereof
10/30/2008WO2008129951A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
10/30/2008WO2008129851A1 Nitric oxide synthase activator
10/30/2008WO2008129846A1 Pharmaceutical composition
10/30/2008WO2008129802A1 Agent for lowering serum uric acid level and food or drink with indication of lowering serum uric acid level
10/30/2008WO2008129624A1 Pyrazolopyridine-4-yl-pyrazolone derivative, addition salt thereof and phosphodiesterase inhibitor containing the same as active ingredient
10/30/2008WO2008129288A2 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008129077A2 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation
10/30/2008WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
10/30/2008WO2008128653A1 Oxazolidinone for the treatment and prophylaxis of pulmonary hypertension
10/30/2008WO2008128647A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008WO2008128366A1 Active ingredient combination for the prophylaxis of occlusive vascular diseases and cancer
10/30/2008WO2008100635A8 1- [3- (monocyclic amino) propyl] - 4, 5, 6, 7-tetrahydro-1h-pyrazolo [4, 3-c] -pyridines as modulators of cathepsin s
10/30/2008WO2008095841A3 Nitric oxide donor compounds
10/30/2008WO2008075206A3 Cell-matrix microspheres, methods for preparation and applications
10/30/2008WO2008057497A3 Small organic molecule regulators of cell proliferation
10/30/2008US20080269487 6-{[1-(carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline; prevent, treat tumours which are sensitive to inhibition of erbB receptor tyrosine kinases
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269346 B-Blocker Pharmacogenetics in Heart Failure
10/30/2008US20080269345 Quarternary Ammonium Compound, Process for Producing the Same, Therapeutic Agent for Cerebrovascular Disorder, and Therapeutic Agent for Heart Disease
10/30/2008US20080269343 Galenic formulations of organic compounds
10/30/2008US20080269336 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/30/2008US20080269331 Omega -3 series polyunsaturated fatty acids are selected from eicosapentanoic acid, docosahexaenoic acid, eicosapentanoic acid, ethyl ester, docosahexaenoic acid, ethyl ester; infarct of the myocardium; coronary ischemia; atrial fibrillation
10/30/2008US20080269305 R)-N-{2-Butyl-3-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazol-4-ylmethyl}-2-(2-hydroxycarbamoyl-3-phenyl-propionylamino)succinamic Acid; AT1 receptor antagonist and neprilysin (NEP) enzyme inhibition activity; hypertension, heart failure
10/30/2008US20080269300 Substituted Phenylaminothiazoles and Use Thereof
10/30/2008US20080269293 1-[2-(5-Methyl-2-o-tolyl-2H-pyrazol-3-yloxy)-phenyl]-3-(4-trifluoromethoxy-phenyl)-urea, for example; useful as P2Y1 antagonists for treating thromboembolic disorders
10/30/2008US20080269289 Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions
10/30/2008US20080269284 e.g. 4-[(3,5-bistrifluoromethylbenzyl)-(2-propyl-2H-tetrazol-5-yl)amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis
10/30/2008US20080269277 Pyrrolopyridine-2-Carboxylic Acid Hydrazides
10/30/2008US20080269273 Administering loratadine and montelukast; cardiovascular disorders; antiallergens; antiinflammatory agents
10/30/2008US20080269268 Substituted Phenylamino-Pyrimidines
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269255 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
10/30/2008US20080269247 Chemokine Inhibiting Piperazine Derivatives and Their Use to Treat Myocarditis
10/30/2008US20080269241 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269230 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
10/30/2008US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269213 8-Hydroxyquinoline compounds and methods thereof
10/30/2008US20080269211 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders
10/30/2008US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders
10/30/2008US20080269188 Determine variable response in patients sensitive to cardiovascular disease, high cholesterol, diabetes, metabolism disorders; detecting concentration of polypeptide containing proline as indicator of good response to statin therapy; drug design
10/30/2008US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
10/30/2008US20080269176 New Salts
10/30/2008US20080269159 Compositions and methods for regulation of smooth muscle cells and blood pressure
1 ... 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 ... 1595